Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

S. Korea To Invest $4.5 Billion In Two Medical R&D Centers

This article was originally published in PharmAsia News

Executive Summary

The South Korean government plans to invest more than $4.5 billion in a pair of industrial clusters dedicated to medical research for innovative drugs, medical devices and clinical trials. The government goal is to have the two medical hubs constructed by 2012 and capable of developing 16 types of drugs and 18 types of devices over 30 years. The Ministry for Health, Welfare and Family Affairs said the investment would pay for itself by creating centers that would generate more than $66 billion worth of medical services, spin-offs and jobs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072452

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel